Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Groner

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Current Signal Transduction Therapy|July 22, 2014
Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling LoopsViktoria von Manstein, Chul Min Yang, Diane Richter, et al.
Molecular Cancer Research : MCR|March 24, 2004
The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cellsKerstin Nagel-Wolfrum, Claudia Buerger, Ilka Wittig, et al.
JAK-STAT|September 24, 2013
A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cellsCorina Borghouts, Natalia Delis, Boris Brill, et al.
The Journal of Biological Chemistry|July 5, 2003
Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cellsClaudia Buerger, Kerstin Nagel-Wolfrum, Christian Kunz, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cellsAxel Weber, Corina Borghouts, Christian Brendel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survivalSnehal Dabir, Amy Kluge, Adam Kresak, et al.
Cancers|March 27, 2015
Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia CellsAxel Weber, Corina Borghouts, Christian Brendel, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Inhibition of Stat3 by peptide aptamer rS3-PA enhances growth suppressive effects of irinotecan on colorectal cancer cellsAxel Weber, Corina Borghouts, Natalia Delis, et al.
Blood|April 4, 2002
The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complexAlexander B Maurer, Christian Wichmann, Alexandra Gross, et al.
International Journal of Cancer|May 21, 2015
Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypesChul Min Yang, Tomohiro Chiba, Boris Brill, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Current Signal Transduction Therapy|July 22, 2014
Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling LoopsViktoria von Manstein, Chul Min Yang, Diane Richter, et al.
Molecular Cancer Research : MCR|March 24, 2004
The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cellsKerstin Nagel-Wolfrum, Claudia Buerger, Ilka Wittig, et al.
JAK-STAT|September 24, 2013
A membrane penetrating peptide aptamer inhibits STAT3 function and suppresses the growth of STAT3 addicted tumor cellsCorina Borghouts, Natalia Delis, Boris Brill, et al.
The Journal of Biological Chemistry|July 5, 2003
Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cellsClaudia Buerger, Kerstin Nagel-Wolfrum, Christian Kunz, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2013
The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cellsAxel Weber, Corina Borghouts, Christian Brendel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survivalSnehal Dabir, Amy Kluge, Adam Kresak, et al.
Cancers|March 27, 2015
Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia CellsAxel Weber, Corina Borghouts, Christian Brendel, et al.
Hormone Molecular Biology and Clinical Investigation|December 2, 2014
Inhibition of Stat3 by peptide aptamer rS3-PA enhances growth suppressive effects of irinotecan on colorectal cancer cellsAxel Weber, Corina Borghouts, Natalia Delis, et al.
Blood|April 4, 2002
The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complexAlexander B Maurer, Christian Wichmann, Alexandra Gross, et al.
International Journal of Cancer|May 21, 2015
Expression of the miR-302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypesChul Min Yang, Tomohiro Chiba, Boris Brill, et al.
Pageof 8